Brinker International stock hits all-time high at 253.72 USD

Brinker International stock hits all-time high at 253.72 USD

Brinker International stock hits all-time high at 253.72 USD
A top Senate Democrat has expressed concerns that brokerage giant Compass Inc.’s private listings network could create a “two-tiered housing market” that “increases risks of civil rights violations” in a letter to the company’s CEO, Realtor.com® can exclusively reveal. Sen. Elizabeth Warren (D-MA), ranking member of the Senate Committee on Banking, Housing and Urban Affairs,…
Marcus & Millichap announced the sale of a LA Fitness-anchored, four-suite retail property in Mundelein, Illinois. The property sold for $13.976 millkion. Marcus & Millichap Capital Corporation, a subsidiary of Marcus & Millichap, arranged $9.78 million in acquisition financing. “The Sharko | Weisenbeck | Mendoza Group was the second broker to list this deal, speaking…
Imagine going in for your annual physical only to discover that your doctor has no formal education in medicine, no license, and no insurance policy in case something goes wrong. It’s a disconcerting thought—to say the least—and, depending on where you live, it may be the reality for your home purchase. Home inspectors play a…
1 min read Last Updated : Aug 21 2026 | 5:21 PM IST Nearly three-fourths of India’s population has accessed credit at least once, with early growth primarily driven by expanding credit access, reveals TransUnion CIBIL’s new report titled ‘Unlocking Access: Journey of Credit Expansion in India’. It presents a study from March 2017…
The US bond market faces a test of investor demand for longer-dated maturities, with auctions of 10- and 30-year Treasuries highlighting an otherwise light week for economic events. Processing Content The sale of benchmark 10-year notes comes Wednesday, followed by 30-year bonds a day later as part of the Treasury’s $119 billion week of auctions….
Vertex Pharmaceuticals (VRTX +2.10%) has dominated the market for cystic fibrosis (CF) medicines since it earned approval for its first drug in this niche in 2012. To this day, most of the company’s revenue comes from its CF franchise. In the second quarter, Vertex posted $3.33 billion in revenue, representing a 12% year-over-year increase. CF-related…